A new drug application (NDA) has been submitted to the FDA seeking approval of rusfertide, an investigational hepcidin ...
The Ministry of Culture officially inaugurated the “Berklee in Santo Domingo 2026” international academic program on Monday, 5 January 2026. The initiative has gathered nearly 200 young musicians from ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing in the registrational PIONEER program across 2 key ...
Digital Camera World on MSN
Lexar celebrates its 30th birthday and reveals new storage solutions for AI workloads
For its latest development, Lexar is introducing AI Storage Core: a range of storage products designed to be compatible with ...
BMB-101 demonstrated significant anti-seizure benefit in both cohorts with favorable safety and tolerability Absence: 73.1% ...
Complex on MSN
10 Fashion Trends We Think Will Run Streetwear in 2026
The trend cycle has never moved faster than it does now. It feels like every week a new “core” or micro trend hits social ...
Breakthrough Therapy Designation granted to Privosegtor, a neuroprotective candidate, for the treatment of optic neuritis Privosegtor is advancing ...
FinanceBuzz on MSN
10 of the highest paying dividend stocks you could buy right now
Here are 10 of the highest-paying dividend stocks you can buy right now, offering strong yields, reliable payouts, and ...
As Lexar celebrates its 30th anniversary, the brand reflects on three decades of innovation, engineering excellence, and trusted performance. Since 1996, Lexar has evolved from a pioneer in memory ...
These new product announcements integrate smarter technology ever more seamlessly into users’ creative workflows. Lenovo also ...
The FDA approval of denileukin diftitox (Lymphir) marked a significant shift in this paradigm. As a first-in-class immunotoxin, it employs a dual-action mechanism: directly targeting interleukin-2 (IL ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results